Abstract
The interface of chemistry and biology offers many opportunities to explore different aspects of cell biology. The emerging field of chemical genetics is providing the chemical means to understand biological systems not easily accessible using classical genetic manipulations. In this article, we will discuss how natural product mode of action studies and novel bio-organic manipulation of intracellular protein levels are proving useful in the exploration of cell biology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH (2000) Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275:25733–25741
Crews CM, Splittgerber U (1999) Chemical genetics: exploring and controlling cellular processes with chemical probes. Trends Biochem Sci 24:317–320
Elofsson M, Splittgerber U, Myung J, Mohan R, Crews CM (1999) Towards subunit specific proteasome inhibitors: synthesis and evaluation of peptide α′,β′-epoxyketones. Chem Biol 6:811–82
Groll M, Kim KB, Huber R, Crews CM (2000) Crystal structure of epoxomicin: 20S proteasome reveals molecular basis for selectivity of α′,β′-epoxyketone proteasome inhibitors. J Am Chem Soc 122:1237–123
Hanada M, Sugawara K, Kaneta K, Toda S, Nishiyama Y, Tomita K, Yamamoto H, Konishi M, Oki T (1992) Epoxomicin, a new antitumor agent of microbial origin. J Antibiot 45:1746–1752
Heptinstall S, Awang DV, Dawson BA, Kindack D, Knight DW, May J (1992) Parthenolide content and bioactivity of feverfew(Tanacetum parthenium (L) Schultz-Bip.) Estimation of commercial and authenticated feverfew products. J Pharm Pharmacol 44:391–395
Hon WC, Wilson MI, Harlos K, Claridge TD, Schofield CJ, Pugh CW, Maxwell PH, Ratcliffe PJ, Stuart DI, Jones EY (2002) Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature 417:975–978
Jentsch S (1992) The ubiquitin-conjugation system. Annu Rev Genet 26:179–207
Koh B, Crews CM (2002) Chemical genetics: a small molecule approach to neurobiology. Neuron 36:563–566
Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM (2001) The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem Biol 8:759–766
Liu S, Widom J, Kemp CW, Crews CM, Clardy J (1998) Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science 282:1324–1327
Meng L, Kwok BHB, Sin N, Crews CM (1999a) Eponemycin exerts its antitumor effect through inhibition of proteasome function. Cancer Res 59:2798–2801
Meng L, Mohan R, Kwok BHB, Elofsson M, Sin N, Crews CM (1999b) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity. Proc Natl Acad Sci U S A 96:10403–10408
Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP (2002) Structure of an HIF-1alpha-pVHL complex: hydroxyproline recognition in signaling. Science 296:1886–1889
Sakamoto KM, Kim KB, Kumagai A, Mercurio F, Crews CM, Deshaies RJ (2001) Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc Natl Acad Sci U S A 98:8554–8559
Schneekloth JS Jr, Fonseca FN, Koldobskiy M, Mandal A, Deshaies R, Sakamoto K, Crews CM (2004) Chemical genetic control of protein levels: selective in vivo targeted degradation. J Am Chem Soc 126:3748–3754
Schreiber SL (1998) Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg Med Chem 6:1127–1152
Seufert W, Jentsch S (1992) In vivo function of the proteasome in the ubiquitin pathway. EMBO J 11:3077–3080
Sin N, Meng L, Wang MQW, Wen JJ, Bornmann WG, Crews CM (1997) The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci U S A 94:6099–6103
Sin N, Meng L, Auth H, Crews CM (1998) Eponemycin analogs: synthesis and use as probes of angiogenesis. Bioorg Med Chem 6:1209–1217
Sin N, Kim K, Elofsson M, Meng L, Auth H, Kwok BHB, Crews CM (1999) Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology. Bioorg Med Chem Lett 9:2283–2288
Sugawara K, Hatori M, Nishiyama Y, Tomita K, Kamei H, Konishi M, Oki T (1990) Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity. J Antibiot 43:8–18
Tanimoto K, Makino Y, Pereira T, Poellinger L (2000) Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 19:4298–4309
Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 97:13003–13008
Yeh JR, Crews CM (2003) Chemical genetics: adding to the developmental biology toolbox. Dev Cell 5:11–19
Yeh JR, Mohan R, Crews CM (2000) The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest. Proc Natl Acad Sci U S A 97:12782–12787
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gough, J.D., Crews, C.M. (2006). Probing Protein Function with Small Molecules. In: Jaroch, S., Weinmann, H. (eds) Chemical Genomics. Ernst Schering Research Foundation Workshop, vol 58. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-37635-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-540-37635-4_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-27865-8
Online ISBN: 978-3-540-37635-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)